Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Asset Writedowns and Impairment (2020 - 2025)

Marimed (MRMD) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $60000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 129.27% to $60000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 570.83% year-over-year, with the annual reading at $1.6 million for FY2025, 570.83% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $60000.0 at Marimed, up from -$122000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $1.4 million in Q1 2025, with the low at -$205000.0 in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is $204125.0, with a median of $37500.0 recorded in 2021.
  • The sharpest move saw Asset Writedowns and Impairment crashed 405.0% in 2023, then surged 1806.67% in 2025.
  • Over 5 years, Asset Writedowns and Impairment stood at $7000.0 in 2021, then surged by 471.43% to $40000.0 in 2022, then surged by 512.5% to $245000.0 in 2023, then plummeted by 183.67% to -$205000.0 in 2024, then skyrocketed by 129.27% to $60000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $60000.0, -$122000.0, and $256000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.